Blood Culture Tests Market by Product (Consumables, Instruments), Method (Manual, Automated), Technology (Culture-Based, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospital, Academic Research), Region - Global Forecast to 2031
The global blood culture tests market is anticipated to grow from USD 6.66 billion in 2026 to USD 8.94 billion by 2031, reflecting a CAGR of 6.1%. Market growth is supported by the rising incidence of bloodstream infections (BSIs), sepsis, and healthcare-associated infections (HAIs), along with increasing concerns regarding antimicrobial resistance (AMR). Blood culture remains an important diagnostic approach for detecting viable microorganisms in the bloodstream and supporting appropriate antimicrobial treatment decisions. The increasing number of hospital admissions, surgical procedures, and critically ill and immunocompromised patients is further contributing to blood culture testing volumes. Additionally, the growing adoption of automated blood culture systems, rapid microbial identification technologies, and integrated microbiology workflows, coupled with expanding diagnostic laboratory infrastructure, is accelerating market growth.
“Consumables to register the highest CAGR in the blood culture tests market from 2026 to 2031”
Based on product, the consumables segment is likely to record the highest CAGR during the forecast period. This segment is primarily driven by the recurring utilization of blood culture bottles, culture media, reagents, and other associated consumables required for routine blood culture testing. Unlike instruments, which are generally capital purchases with relatively long replacement cycles, blood culture bottles and related consumables are required for each test, creating sustained demand in proportion to testing volumes. Increasing diagnosis of sepsis and bloodstream infections, rising hospital and critical care admissions, and greater emphasis on early identification of causative pathogens are contributing to higher consumption across hospital microbiology and diagnostic laboratories. Furthermore, the expanding installed base of automated blood culture platforms is generating recurring demand for compatible aerobic, anaerobic, and pediatric blood culture bottles and media, further strengthening the segment’s position in the global market.
“Bacteremia segment captured the largest share of the blood culture tests market in 2025”
Based on application, the bacteremia segment accounted for the largest market share in 2025, owing to the widespread use of blood cultures for the detection of bacterial bloodstream infections and identification of causative pathogens. Bacteremia can occur secondary to infections originating from the respiratory tract, urinary tract, gastrointestinal tract, skin and soft tissues, as well as from intravascular catheters and other invasive procedures, resulting in substantial testing demand across hospital settings. Blood culture remains a key diagnostic method for confirming viable bacteria in the bloodstream and obtaining isolates for subsequent pathogen identification and antimicrobial susceptibility testing (AST).
“Asia Pacific to register fastest growth rate in blood culture tests market between 2026 and 2031”
Based on region, Asia Pacific is expected to witness the fastest growth rate during the forecast period. The regional market growth is supported by expanding healthcare infrastructure, increasing healthcare expenditure, and continued development of hospital and clinical laboratory capabilities across emerging economies. The substantial burden of infectious diseases, bloodstream infections, sepsis, and healthcare-associated infections, coupled with large patient populations and increasing hospital admissions, is driving demand for blood culture testing across the region. Governments and private healthcare providers are investing in diagnostic laboratory infrastructure, microbiology capabilities, hospital capacity, and healthcare accessibility, supporting a gradual transition from conventional workflows toward automated blood culture systems in several markets. Furthermore, growing awareness of antimicrobial resistance, antimicrobial stewardship, and the importance of early pathogen identification, along with increasing adoption of automated microbiology platforms and rapid diagnostic technologies, is contributing to market expansion. Major countries supporting regional growth include China, India, Japan, South Korea, and other rapidly developing Asia Pacific healthcare markets.
Breakdown of primary participants in the blood culture tests market is as follows:
Research Coverage:
This research report categorizes the blood culture tests market by product (consumables, instruments, and software & services), method (conventional/manual blood culture and automated blood culture), technology (culture-based, molecular, and proteomics), application (bacteremia, fungemia, and mycobacterial detection), end user (hospital laboratories, reference laboratories, academic research laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood culture tests market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and key strategies, such as partnerships, collaborations, expansions, agreements, product launches, and recent developments in the market. This report covers the competitive analysis of upcoming startups in the blood culture tests ecosystem.
Reasons to Buy This Report:
The report will help leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall blood culture tests market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
“Consumables to register the highest CAGR in the blood culture tests market from 2026 to 2031”
Based on product, the consumables segment is likely to record the highest CAGR during the forecast period. This segment is primarily driven by the recurring utilization of blood culture bottles, culture media, reagents, and other associated consumables required for routine blood culture testing. Unlike instruments, which are generally capital purchases with relatively long replacement cycles, blood culture bottles and related consumables are required for each test, creating sustained demand in proportion to testing volumes. Increasing diagnosis of sepsis and bloodstream infections, rising hospital and critical care admissions, and greater emphasis on early identification of causative pathogens are contributing to higher consumption across hospital microbiology and diagnostic laboratories. Furthermore, the expanding installed base of automated blood culture platforms is generating recurring demand for compatible aerobic, anaerobic, and pediatric blood culture bottles and media, further strengthening the segment’s position in the global market.
“Bacteremia segment captured the largest share of the blood culture tests market in 2025”
Based on application, the bacteremia segment accounted for the largest market share in 2025, owing to the widespread use of blood cultures for the detection of bacterial bloodstream infections and identification of causative pathogens. Bacteremia can occur secondary to infections originating from the respiratory tract, urinary tract, gastrointestinal tract, skin and soft tissues, as well as from intravascular catheters and other invasive procedures, resulting in substantial testing demand across hospital settings. Blood culture remains a key diagnostic method for confirming viable bacteria in the bloodstream and obtaining isolates for subsequent pathogen identification and antimicrobial susceptibility testing (AST).
“Asia Pacific to register fastest growth rate in blood culture tests market between 2026 and 2031”
Based on region, Asia Pacific is expected to witness the fastest growth rate during the forecast period. The regional market growth is supported by expanding healthcare infrastructure, increasing healthcare expenditure, and continued development of hospital and clinical laboratory capabilities across emerging economies. The substantial burden of infectious diseases, bloodstream infections, sepsis, and healthcare-associated infections, coupled with large patient populations and increasing hospital admissions, is driving demand for blood culture testing across the region. Governments and private healthcare providers are investing in diagnostic laboratory infrastructure, microbiology capabilities, hospital capacity, and healthcare accessibility, supporting a gradual transition from conventional workflows toward automated blood culture systems in several markets. Furthermore, growing awareness of antimicrobial resistance, antimicrobial stewardship, and the importance of early pathogen identification, along with increasing adoption of automated microbiology platforms and rapid diagnostic technologies, is contributing to market expansion. Major countries supporting regional growth include China, India, Japan, South Korea, and other rapidly developing Asia Pacific healthcare markets.
Breakdown of primary participants in the blood culture tests market is as follows:
- By Company Type: Tier 1 (31%), Tier 2 (40%), and Tier 3 (29%)
- By Designation: C-level Executives (30%), Directors (24%), and Others (46%)
- By Region: North America (52%), Europe (20%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
Research Coverage:
This research report categorizes the blood culture tests market by product (consumables, instruments, and software & services), method (conventional/manual blood culture and automated blood culture), technology (culture-based, molecular, and proteomics), application (bacteremia, fungemia, and mycobacterial detection), end user (hospital laboratories, reference laboratories, academic research laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood culture tests market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and key strategies, such as partnerships, collaborations, expansions, agreements, product launches, and recent developments in the market. This report covers the competitive analysis of upcoming startups in the blood culture tests ecosystem.
Reasons to Buy This Report:
The report will help leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall blood culture tests market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (Increasing number of sepsis patients and cost of treatment, Rapid growth in geriatric population with chronic diseases, High incidence of nosocomial bloodstream infections, Growing demand for rapid diagnostic techniques with faster turnaround times, High prevalence of infectious diseases globally), restraints (High cost of automated blood culture instruments, Lack of trained laboratory technicians) opportunities (Growth opportunities in emerging economies, Increased need to identify antibiotic-resistant microorganisms) and Challenges (Long turnaround time associated with conventional blood culture workflows, Blood culture contamination and pre-analytical errors) influencing the blood culture tests market growth
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the blood culture tests market
- Market Development: Comprehensive information about lucrative markets; the report analyzes the blood culture tests market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood culture tests market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Waters Corporation (US), bioM?rieux (France), Thermo Fisher Scientific, Inc. (US), and DiaSorin S.p.A. (Italy)
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 BLOOD CULTURE TESTS MARKET OVERVIEW
3.2 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2026 VS. 2031
3.3 BLOOD CULTURE TESTS MARKET, BY METHOD, 2026 VS. 2031
3.4 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2026 VS. 2031
3.5 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2026 VS. 2031
3.6 BLOOD CULTURE TESTS MARKET, BY END USER, 2026 VS. 2031
3.7 BLOOD CULTURE TESTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing number of sepsis patients and rising cost of treatment
4.2.1.2 Rapid growth in geriatric population with chronic diseases
4.2.1.3 High incidence of bloodstream infections
4.2.1.4 Growing demand for rapid diagnostic techniques
4.2.1.5 High prevalence of infectious diseases
4.2.2 RESTRAINTS
4.2.2.1 High cost of automated blood culture instruments
4.2.2.2 Lack of trained laboratory technicians
4.2.3 OPPORTUNITIES
4.2.3.1 Growth opportunities in emerging economies
4.2.3.2 Increased need to identify antibiotic-resistant microorganisms
4.2.4 CHALLENGES
4.2.4.1 Long turnaround time associated with conventional blood culture workflows
4.2.4.2 Blood culture contamination and pre-analytical errors
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN BLOOD CULTURE TESTS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 KEY MOVES & STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 BLOOD CULTURE TESTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
BY KEY PLAYER, 2024–2026
5.6.2 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
BY REGION, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 382100)
5.7.2 EXPORT SCENARIO (HS CODE 382100)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 ENHANCED STAINING AND WORKFLOW PROTOCOLS IMPROVE DETECTION OF FASTIDIOUS ORGANISMS IN POSITIVE BLOOD CULTURES
5.11.2 RAPID BLOOD CULTURE IDENTIFICATION AND ANTIMICROBIAL STEWARDSHIP REDUCE TIME TO OPTIMAL THERAPY
5.12 IMPACT OF 2025 US TARIFFS ON BLOOD CULTURE TESTS MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Hospital laboratories
5.12.5.2 Reference laboratories
5.12.5.3 Academic research laboratories
5.12.5.4 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY TECHNOLOGIES
6.1.1 CULTURE-BASED TECHNOLOGIES
6.1.2 MOLECULAR TECHNOLOGIES
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.4 PATENT ANALYSIS
6.4.1 LIST OF MAJOR PATENTS
6.5 FUTURE APPLICATIONS
6.6 IMPACT OF AI/GENERATIVE AI ON BLOOD CULTURE TESTS MARKET
6.6.1 INTRODUCTION
6.6.2 TOP USE CASES & MARKET POTENTIAL
6.6.3 KEY COMPANIES IMPLEMENTING AI
6.6.4 FUTURE OF AI
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN BLOOD CULTURE TESTS
7.2.1.1 Eco-friendly initiatives
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS ACROSS VARIOUS END USERS
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 BLOOD CULTURE TESTS MARKET, BY OFFERING
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 BLOOD CULTURE MEDIA
9.2.1.1 Aerobic blood culture media
9.2.1.1.1 Growing blood culture volumes to support aerobic media market growth
9.2.1.2 Pediatric aerobic blood culture media
9.2.1.2.1 Rising pediatric sepsis burden to drive demand for specialized low-volume blood culture bottles
9.2.1.3 Anaerobic blood culture media
9.2.1.3.1 Increased need for routine diagnosis of bacteria in blood culture to drive segment
9.2.1.4 Mycobacterial blood culture media
9.2.1.4.1 Persistent global TB burden to drive demand for mycobacterial blood culture media
9.2.1.5 Fungi/yeast blood culture media
9.2.1.5.1 Easy identification and characterization of special fungal species to drive segment
9.2.2 ASSAY KITS & REAGENTS
9.2.2.1 Increased need for rapid identification of bacteria and yeast from positive blood cultures to drive market
9.2.3 BLOOD CULTURE ACCESSORIES
9.2.3.1 Growing number of blood culture tests to drive market
9.3 INSTRUMENTS
9.3.1 AUTOMATED BLOOD CULTURE SYSTEMS
9.3.1.1 Need for automated imaging systems and advanced algorithms to drive market
9.3.2 SUPPORTING LABORATORY EQUIPMENT
9.3.2.1 Incubators
9.3.2.1.1 Incubators to provide optimal environment with adequate temperature and oxygen levels for microbial growth
9.3.2.2 Colony counters
9.3.2.2.1 Colony counters to increase direct image scanning and analysis capability
9.3.2.3 Microscopes
9.3.2.3.1 Growing emphasis on rapid preliminary identification to fuel demand for microscopes
9.3.2.4 Gram stainers
9.3.2.4.1 Gram strainers to guide initial antibiotic section and appropriate empirical therapy
9.3.2.5 Other supporting equipment
9.4 SOFTWARE & SERVICES
9.4.1 INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET
10 BLOOD CULTURE TESTS MARKET, BY METHOD
10.1 INTRODUCTION
10.2 CONVENTIONAL/MANUAL BLOOD CULTURES
10.2.1 LOWER CAPITAL REQUIREMENTS TO DRIVE ADOPTION OF CONVENTIONAL BLOOD CULTURE METHODS IN RESOURCE-CONSTRAINED SETTINGS
10.3 AUTOMATED BLOOD CULTURES
10.3.1 NEED FOR FASTER TURNAROUND TIMES TO FUEL TRANSITION TOWARD AUTOMATED BLOOD CULTURE METHODS
11 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 CULTURE-BASED TECHNOLOGIES
11.2.1 ADVANCEMENTS IN AUTOMATED DETECTION TO STRENGTHEN CULTURE-BASED TECHNOLOGIES SEGMENT
11.3 MOLECULAR TECHNOLOGIES
11.3.1 PCR
11.3.1.1 Reduced risk of contamination and easy detection of bloodstream infections to drive segment
11.3.2 MICROARRAYS
11.3.2.1 Determination of better genotyping characterization and identification of bacterial infections to drive segment
11.3.3 PNA-FISH
11.3.3.1 Rapid species-level identification to strengthen role of PNA-FISH in bloodstream infection diagnosis
11.4 OTHER TECHNOLOGIES
12 BLOOD CULTURE TESTS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 BACTEREMIA
12.2.1 GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET
12.3 FUNGEMIA
12.3.1 INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET
12.4 MYCOBACTERIAL DETECTION
12.4.1 HIGH GLOBAL TB BURDEN AND CONCENTRATION OF CASES IN HIGH-RISK POPULATIONS TO DRIVE DEMAND
13 BLOOD CULTURE TESTS MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITAL LABORATORIES
13.2.1 INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET
13.3 REFERENCE LABORATORIES
13.3.1 GROWING REFERRAL AND SPECIALIZED TESTING NEEDS TO FUEL REFERENCE LABORATORY DEMAND
13.4 ACADEMIC RESEARCH LABORATORIES
13.4.1 GROWING FOCUS ON NOVEL DIAGNOSTIC DEVELOPMENT TO FUEL BLOOD CULTURE TESTING IN RESEARCH LABORATORIES
13.5 OTHER END USERS
14 BLOOD CULTURE TESTS MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
14.2.2 US
14.2.2.1 Rising sepsis burden and antimicrobial resistance to drive demand for blood culture testing in US
14.2.3 CANADA
14.2.3.1 Increasing MRSA bloodstream infection burden to strengthen demand
14.3 BLOOD CULTURE TESTS MARKET: VOLUME ANALYSIS
14.3.1 INTRODUCTION
14.3.2 NORTH AMERICA: BLOOD CULTURE SETS VOLUME
14.4 EUROPE
14.4.1 EUROPE: MACROECONOMIC OUTLOOK
14.4.2 GERMANY
14.4.2.1 Expanding healthcare investment and inpatient care spending to drive adoption
14.4.3 UK
14.4.3.1 Rising AMR-related bacteremia and E. coli prevalence to expand blood culture testing
14.4.4 FRANCE
14.4.4.1 Rising healthcare expenditure and high physician density to strengthen adoption
14.4.5 ITALY
14.4.5.1 Expanding microbiology surveillance and continued healthcare investment to support Italy’s market
14.4.6 SPAIN
14.4.6.1 Growing elderly population and healthcare utilization to sustain demand
14.4.7 REST OF EUROPE
14.5 ASIA PACIFIC
14.5.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
14.5.2 CHINA
14.5.2.1 Expanding healthcare investment and hospital capacity to drive blood culture testing demand in China
14.5.3 JAPAN
14.5.3.1 Extensive hospital infrastructure to sustain demand
14.5.4 INDIA
14.5.4.1 Rising government healthcare expenditure to support expansion of diagnostic and laboratory infrastructure
14.5.5 REST OF ASIA PACIFIC
14.6 LATIN AMERICA
14.6.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
14.6.2 BRAZIL
14.6.2.1 Growth in hospital-service expenditure to support modernization of Brazil's clinical diagnostic infrastructure
14.6.3 MEXICO
14.6.3.1 Strengthening AMR laboratory requirements to support adoption
14.6.4 REST OF LATIN AMERICA
14.7 MIDDLE EAST & AFRICA
14.7.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD CULTURE TESTS MARKET
15.3 REVENUE ANALYSIS, 2023–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Offering footprint
15.5.5.4 Method footprint
15.5.5.5 Technology footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.5.1 Detailed list of key startups/SMEs
15.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
15.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.7.1 FINANCIAL METRICS
15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 WATERS CORPORATION
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 BIOM?RIEUX
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 THERMO FISHER SCIENTIFIC, INC.
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Deals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 DANAHER CORPORATION
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 MnM view
16.1.4.3.1 Right to win
16.1.4.3.2 Strategic choices
16.1.4.3.3 Weaknesses & competitive threats
16.1.5 F. HOFFMANN-LA ROCHE LTD.
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 DIASORIN S.P.A.
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.6.3 Recent developments
16.1.6.3.1 Product approvals
16.1.7 BRUKER CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches & approvals
16.1.7.3.2 Deals
16.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Product launches
16.1.9 AUTOBIO DIAGNOSTICS CO., LTD.
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Deals
16.1.10 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.
16.1.10.1 Business overview
16.1.10.2 Products offered
16.2 OTHER PLAYERS
16.2.1 HIMEDIA LABORATORIES PVT. LTD.
16.2.2 BIOBASE GROUP
16.2.3 LABOTRONICS SCIENTIFIC
16.2.4 HARDY DIAGNOSTICS
16.2.5 BIOLOG, INC.
16.2.6 ZHUHAI DEER BIOENGINEERING CO., LTD.
16.2.7 ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.
16.2.8 FISON INSTRUMENTS LTD.
16.2.9 BINDER GMBH
16.2.10 LABTRON EQUIPMENT LTD.
16.2.11 LABNICS LTD.
16.2.12 COPAN ITALIA S.P.A.
16.2.13 GREINER BIO-ONE INTERNATIONAL GMBH
16.2.14 LIOFILCHEM S.R.L.
16.2.15 TITAN BIOTECH LTD.
17 RESEARCH METHODOLOGY
17.1 RESEARCH DATA
17.2 RESEARCH APPROACH
17.2.1 SECONDARY RESEARCH
17.2.1.1 Key data from secondary sources
17.2.2 PRIMARY DATA
17.2.2.1 Key data from primary sources
17.2.2.2 Key industry insights
17.3 MARKET SIZE ESTIMATION
17.3.1 BOTTOM-UP APPROACH
17.3.1.1 Approach 1: Company revenue estimation approach
17.3.1.2 Approach 2: Presentations of companies and primary interviews
17.3.1.3 Growth forecast
17.3.2 TOP-DOWN APPROACH
17.4 MARKET BREAKDOWN & DATA TRIANGULATION
17.5 MARKET SHARE ANALYSIS
17.6 RESEARCH ASSUMPTIONS
17.6.1 GROWTH RATE ASSUMPTIONS
17.7 RESEARCH LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 BLOOD CULTURE TESTS MARKET OVERVIEW
3.2 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2026 VS. 2031
3.3 BLOOD CULTURE TESTS MARKET, BY METHOD, 2026 VS. 2031
3.4 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2026 VS. 2031
3.5 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2026 VS. 2031
3.6 BLOOD CULTURE TESTS MARKET, BY END USER, 2026 VS. 2031
3.7 BLOOD CULTURE TESTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing number of sepsis patients and rising cost of treatment
4.2.1.2 Rapid growth in geriatric population with chronic diseases
4.2.1.3 High incidence of bloodstream infections
4.2.1.4 Growing demand for rapid diagnostic techniques
4.2.1.5 High prevalence of infectious diseases
4.2.2 RESTRAINTS
4.2.2.1 High cost of automated blood culture instruments
4.2.2.2 Lack of trained laboratory technicians
4.2.3 OPPORTUNITIES
4.2.3.1 Growth opportunities in emerging economies
4.2.3.2 Increased need to identify antibiotic-resistant microorganisms
4.2.4 CHALLENGES
4.2.4.1 Long turnaround time associated with conventional blood culture workflows
4.2.4.2 Blood culture contamination and pre-analytical errors
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN BLOOD CULTURE TESTS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 KEY MOVES & STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 BLOOD CULTURE TESTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
BY KEY PLAYER, 2024–2026
5.6.2 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
BY REGION, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 382100)
5.7.2 EXPORT SCENARIO (HS CODE 382100)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 ENHANCED STAINING AND WORKFLOW PROTOCOLS IMPROVE DETECTION OF FASTIDIOUS ORGANISMS IN POSITIVE BLOOD CULTURES
5.11.2 RAPID BLOOD CULTURE IDENTIFICATION AND ANTIMICROBIAL STEWARDSHIP REDUCE TIME TO OPTIMAL THERAPY
5.12 IMPACT OF 2025 US TARIFFS ON BLOOD CULTURE TESTS MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Hospital laboratories
5.12.5.2 Reference laboratories
5.12.5.3 Academic research laboratories
5.12.5.4 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY TECHNOLOGIES
6.1.1 CULTURE-BASED TECHNOLOGIES
6.1.2 MOLECULAR TECHNOLOGIES
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.4 PATENT ANALYSIS
6.4.1 LIST OF MAJOR PATENTS
6.5 FUTURE APPLICATIONS
6.6 IMPACT OF AI/GENERATIVE AI ON BLOOD CULTURE TESTS MARKET
6.6.1 INTRODUCTION
6.6.2 TOP USE CASES & MARKET POTENTIAL
6.6.3 KEY COMPANIES IMPLEMENTING AI
6.6.4 FUTURE OF AI
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN BLOOD CULTURE TESTS
7.2.1.1 Eco-friendly initiatives
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS ACROSS VARIOUS END USERS
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 BLOOD CULTURE TESTS MARKET, BY OFFERING
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 BLOOD CULTURE MEDIA
9.2.1.1 Aerobic blood culture media
9.2.1.1.1 Growing blood culture volumes to support aerobic media market growth
9.2.1.2 Pediatric aerobic blood culture media
9.2.1.2.1 Rising pediatric sepsis burden to drive demand for specialized low-volume blood culture bottles
9.2.1.3 Anaerobic blood culture media
9.2.1.3.1 Increased need for routine diagnosis of bacteria in blood culture to drive segment
9.2.1.4 Mycobacterial blood culture media
9.2.1.4.1 Persistent global TB burden to drive demand for mycobacterial blood culture media
9.2.1.5 Fungi/yeast blood culture media
9.2.1.5.1 Easy identification and characterization of special fungal species to drive segment
9.2.2 ASSAY KITS & REAGENTS
9.2.2.1 Increased need for rapid identification of bacteria and yeast from positive blood cultures to drive market
9.2.3 BLOOD CULTURE ACCESSORIES
9.2.3.1 Growing number of blood culture tests to drive market
9.3 INSTRUMENTS
9.3.1 AUTOMATED BLOOD CULTURE SYSTEMS
9.3.1.1 Need for automated imaging systems and advanced algorithms to drive market
9.3.2 SUPPORTING LABORATORY EQUIPMENT
9.3.2.1 Incubators
9.3.2.1.1 Incubators to provide optimal environment with adequate temperature and oxygen levels for microbial growth
9.3.2.2 Colony counters
9.3.2.2.1 Colony counters to increase direct image scanning and analysis capability
9.3.2.3 Microscopes
9.3.2.3.1 Growing emphasis on rapid preliminary identification to fuel demand for microscopes
9.3.2.4 Gram stainers
9.3.2.4.1 Gram strainers to guide initial antibiotic section and appropriate empirical therapy
9.3.2.5 Other supporting equipment
9.4 SOFTWARE & SERVICES
9.4.1 INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET
10 BLOOD CULTURE TESTS MARKET, BY METHOD
10.1 INTRODUCTION
10.2 CONVENTIONAL/MANUAL BLOOD CULTURES
10.2.1 LOWER CAPITAL REQUIREMENTS TO DRIVE ADOPTION OF CONVENTIONAL BLOOD CULTURE METHODS IN RESOURCE-CONSTRAINED SETTINGS
10.3 AUTOMATED BLOOD CULTURES
10.3.1 NEED FOR FASTER TURNAROUND TIMES TO FUEL TRANSITION TOWARD AUTOMATED BLOOD CULTURE METHODS
11 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 CULTURE-BASED TECHNOLOGIES
11.2.1 ADVANCEMENTS IN AUTOMATED DETECTION TO STRENGTHEN CULTURE-BASED TECHNOLOGIES SEGMENT
11.3 MOLECULAR TECHNOLOGIES
11.3.1 PCR
11.3.1.1 Reduced risk of contamination and easy detection of bloodstream infections to drive segment
11.3.2 MICROARRAYS
11.3.2.1 Determination of better genotyping characterization and identification of bacterial infections to drive segment
11.3.3 PNA-FISH
11.3.3.1 Rapid species-level identification to strengthen role of PNA-FISH in bloodstream infection diagnosis
11.4 OTHER TECHNOLOGIES
12 BLOOD CULTURE TESTS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 BACTEREMIA
12.2.1 GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET
12.3 FUNGEMIA
12.3.1 INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET
12.4 MYCOBACTERIAL DETECTION
12.4.1 HIGH GLOBAL TB BURDEN AND CONCENTRATION OF CASES IN HIGH-RISK POPULATIONS TO DRIVE DEMAND
13 BLOOD CULTURE TESTS MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITAL LABORATORIES
13.2.1 INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET
13.3 REFERENCE LABORATORIES
13.3.1 GROWING REFERRAL AND SPECIALIZED TESTING NEEDS TO FUEL REFERENCE LABORATORY DEMAND
13.4 ACADEMIC RESEARCH LABORATORIES
13.4.1 GROWING FOCUS ON NOVEL DIAGNOSTIC DEVELOPMENT TO FUEL BLOOD CULTURE TESTING IN RESEARCH LABORATORIES
13.5 OTHER END USERS
14 BLOOD CULTURE TESTS MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
14.2.2 US
14.2.2.1 Rising sepsis burden and antimicrobial resistance to drive demand for blood culture testing in US
14.2.3 CANADA
14.2.3.1 Increasing MRSA bloodstream infection burden to strengthen demand
14.3 BLOOD CULTURE TESTS MARKET: VOLUME ANALYSIS
14.3.1 INTRODUCTION
14.3.2 NORTH AMERICA: BLOOD CULTURE SETS VOLUME
14.4 EUROPE
14.4.1 EUROPE: MACROECONOMIC OUTLOOK
14.4.2 GERMANY
14.4.2.1 Expanding healthcare investment and inpatient care spending to drive adoption
14.4.3 UK
14.4.3.1 Rising AMR-related bacteremia and E. coli prevalence to expand blood culture testing
14.4.4 FRANCE
14.4.4.1 Rising healthcare expenditure and high physician density to strengthen adoption
14.4.5 ITALY
14.4.5.1 Expanding microbiology surveillance and continued healthcare investment to support Italy’s market
14.4.6 SPAIN
14.4.6.1 Growing elderly population and healthcare utilization to sustain demand
14.4.7 REST OF EUROPE
14.5 ASIA PACIFIC
14.5.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
14.5.2 CHINA
14.5.2.1 Expanding healthcare investment and hospital capacity to drive blood culture testing demand in China
14.5.3 JAPAN
14.5.3.1 Extensive hospital infrastructure to sustain demand
14.5.4 INDIA
14.5.4.1 Rising government healthcare expenditure to support expansion of diagnostic and laboratory infrastructure
14.5.5 REST OF ASIA PACIFIC
14.6 LATIN AMERICA
14.6.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
14.6.2 BRAZIL
14.6.2.1 Growth in hospital-service expenditure to support modernization of Brazil's clinical diagnostic infrastructure
14.6.3 MEXICO
14.6.3.1 Strengthening AMR laboratory requirements to support adoption
14.6.4 REST OF LATIN AMERICA
14.7 MIDDLE EAST & AFRICA
14.7.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD CULTURE TESTS MARKET
15.3 REVENUE ANALYSIS, 2023–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Offering footprint
15.5.5.4 Method footprint
15.5.5.5 Technology footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.5.1 Detailed list of key startups/SMEs
15.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
15.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.7.1 FINANCIAL METRICS
15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 WATERS CORPORATION
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 BIOM?RIEUX
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 THERMO FISHER SCIENTIFIC, INC.
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Deals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 DANAHER CORPORATION
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 MnM view
16.1.4.3.1 Right to win
16.1.4.3.2 Strategic choices
16.1.4.3.3 Weaknesses & competitive threats
16.1.5 F. HOFFMANN-LA ROCHE LTD.
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 DIASORIN S.P.A.
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.6.3 Recent developments
16.1.6.3.1 Product approvals
16.1.7 BRUKER CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches & approvals
16.1.7.3.2 Deals
16.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Product launches
16.1.9 AUTOBIO DIAGNOSTICS CO., LTD.
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Deals
16.1.10 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.
16.1.10.1 Business overview
16.1.10.2 Products offered
16.2 OTHER PLAYERS
16.2.1 HIMEDIA LABORATORIES PVT. LTD.
16.2.2 BIOBASE GROUP
16.2.3 LABOTRONICS SCIENTIFIC
16.2.4 HARDY DIAGNOSTICS
16.2.5 BIOLOG, INC.
16.2.6 ZHUHAI DEER BIOENGINEERING CO., LTD.
16.2.7 ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.
16.2.8 FISON INSTRUMENTS LTD.
16.2.9 BINDER GMBH
16.2.10 LABTRON EQUIPMENT LTD.
16.2.11 LABNICS LTD.
16.2.12 COPAN ITALIA S.P.A.
16.2.13 GREINER BIO-ONE INTERNATIONAL GMBH
16.2.14 LIOFILCHEM S.R.L.
16.2.15 TITAN BIOTECH LTD.
17 RESEARCH METHODOLOGY
17.1 RESEARCH DATA
17.2 RESEARCH APPROACH
17.2.1 SECONDARY RESEARCH
17.2.1.1 Key data from secondary sources
17.2.2 PRIMARY DATA
17.2.2.1 Key data from primary sources
17.2.2.2 Key industry insights
17.3 MARKET SIZE ESTIMATION
17.3.1 BOTTOM-UP APPROACH
17.3.1.1 Approach 1: Company revenue estimation approach
17.3.1.2 Approach 2: Presentations of companies and primary interviews
17.3.1.3 Growth forecast
17.3.2 TOP-DOWN APPROACH
17.4 MARKET BREAKDOWN & DATA TRIANGULATION
17.5 MARKET SHARE ANALYSIS
17.6 RESEARCH ASSUMPTIONS
17.6.1 GROWTH RATE ASSUMPTIONS
17.7 RESEARCH LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
TABLE 2 TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
TABLE 3 BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 5 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 6 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 7 IMPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 8 EXPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 9 BLOOD CULTURE TESTS MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO BLOOD CULTURE TESTS MARKET, 2023–2025
TABLE 12 KEY COMPANIES IMPLEMENTING AI IN BLOOD CULTURE TESTS MARKET
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 GLOBAL STANDARDS IN BLOOD CULTURE TESTS MARKET
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 20 KEY BUYING CRITERIA, BY OFFERING
TABLE 21 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 22 BLOOD CULTURE TESTS MARKET: UNMET NEEDS ACROSS VARIOUS END USERS
TABLE 23 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 24 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 25 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 27 EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 28 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30 EXAMPLES OF BLOOD CULTURE MEDIA
TABLE 31 BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 NORTH AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 EUROPE: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 ASIA PACIFIC: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 LATIN AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 NORTH AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 EUROPE: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 ASIA PACIFIC: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 LATIN AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 NORTH AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 EUROPE: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 ASIA PACIFIC: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 LATIN AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 NORTH AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 EUROPE: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 ASIA PACIFIC: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 LATIN AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58 NORTH AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 EUROPE: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ASIA PACIFIC: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 LATIN AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS
TABLE 63 BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 NORTH AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 EUROPE: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 ASIA PACIFIC: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 LATIN AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 EXAMPLES OF BLOOD CULTURE ACCESSORIES
TABLE 69 BLOOD CULTURE ACCESSORIES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 70 NORTH AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 EUROPE: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 ASIA PACIFIC: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 LATIN AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 76 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 81 AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 82 NORTH AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 EUROPE: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 ASIA PACIFIC: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 LATIN AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87 SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 88 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 INCUBATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 93 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 98 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 GRAM STAINERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 108 NORTH AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 EUROPE: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 LATIN AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117 BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 118 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 EUROPE: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 122 BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 123 EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
TABLE 124 CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 NORTH AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 ASIA PACIFIC: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 LATIN AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
TABLE 130 AUTOMATED BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 131 NORTH AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132 EUROPE: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133 ASIA PACIFIC: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 LATIN AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 136 BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 143 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 EXAMPLES OF MALDI-TOF MS SYSTEMS
TABLE 163 BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 164 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 169 BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 EUROPE: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY REGION, 2024–2031 (USD MILLION)
TABLE 180 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 EUROPE: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184 BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 186 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 EUROPE: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 EUROPE: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195 BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 EUROPE: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 213 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 214 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 216 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 217 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 218 US: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 219 US: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223 US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 224 US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 225 US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 227 US: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 1 ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
TABLE 2 TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
TABLE 3 BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 5 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 6 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 7 IMPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 8 EXPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 9 BLOOD CULTURE TESTS MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO BLOOD CULTURE TESTS MARKET, 2023–2025
TABLE 12 KEY COMPANIES IMPLEMENTING AI IN BLOOD CULTURE TESTS MARKET
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 GLOBAL STANDARDS IN BLOOD CULTURE TESTS MARKET
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 20 KEY BUYING CRITERIA, BY OFFERING
TABLE 21 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 22 BLOOD CULTURE TESTS MARKET: UNMET NEEDS ACROSS VARIOUS END USERS
TABLE 23 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 24 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 25 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 27 EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 28 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30 EXAMPLES OF BLOOD CULTURE MEDIA
TABLE 31 BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 NORTH AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 EUROPE: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 ASIA PACIFIC: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 LATIN AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 NORTH AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 EUROPE: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 ASIA PACIFIC: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 LATIN AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 NORTH AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 EUROPE: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 ASIA PACIFIC: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 LATIN AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 NORTH AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 EUROPE: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 ASIA PACIFIC: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 LATIN AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58 NORTH AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 EUROPE: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ASIA PACIFIC: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 LATIN AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS
TABLE 63 BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 NORTH AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 EUROPE: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 ASIA PACIFIC: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 LATIN AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 EXAMPLES OF BLOOD CULTURE ACCESSORIES
TABLE 69 BLOOD CULTURE ACCESSORIES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 70 NORTH AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 EUROPE: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 ASIA PACIFIC: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 LATIN AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 76 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 81 AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 82 NORTH AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 EUROPE: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 ASIA PACIFIC: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 LATIN AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87 SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 88 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 INCUBATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 93 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 98 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 GRAM STAINERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 108 NORTH AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 EUROPE: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 LATIN AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117 BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 118 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 EUROPE: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 122 BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 123 EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
TABLE 124 CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 NORTH AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 ASIA PACIFIC: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 LATIN AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
TABLE 130 AUTOMATED BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 131 NORTH AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132 EUROPE: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133 ASIA PACIFIC: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 LATIN AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 136 BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 143 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 EXAMPLES OF MALDI-TOF MS SYSTEMS
TABLE 163 BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 164 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 169 BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 EUROPE: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY REGION, 2024–2031 (USD MILLION)
TABLE 180 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 EUROPE: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184 BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 186 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 EUROPE: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 EUROPE: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195 BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 EUROPE: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 213 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 214 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 216 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 217 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 218 US: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 219 US: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223 US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 224 US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 225 US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 227 US: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 BLOOD CULTURE TESTS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 GLOBAL BLOOD CULTURE TESTS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF BLOOD CULTURE TESTS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN BLOOD CULTURE TESTS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING BURDEN OF BLOODSTREAM INFECTIONS AND ANTIMICROBIAL RESISTANCE TO DRIVE MARKET GROWTH
FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10 AUTOMATED BLOOD CULTURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 CULTURE-BASED TECHNOLOGIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 BACTEREMIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 13 HOSPITAL-LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 15 BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 BLOOD CULTURE TESTS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18 BLOOD CULTURE TESTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 19 BLOOD CULTURE TESTS MARKET: ECOSYSTEM ANALYSIS
FIGURE 20 BLOOD CULTURE TESTS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 21 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD CULTURE TESTS MARKET
FIGURE 22 PATENT ANALYSIS FOR BLOOD CULTURE TESTS, JANUARY 2015–DECEMBER 2025
FIGURE 23 MARKET POTENTIAL OF AI IN BLOOD CULTURE TESTS MARKET
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 25 KEY BUYING CRITERIA, BY OFFERING
FIGURE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 27 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025 (USD MILLION)
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2025
FIGURE 30 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31 BLOOD CULTURE TESTS MARKET: COMPANY FOOTPRINT
FIGURE 32 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33 EV/EBITDA OF KEY VENDORS
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35 BLOOD CULTURE TESTS MARKET: BRAND/PRODUCT COMPARISON FOR AUTOMATED BLOOD CULTURE SYSTEMS
FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37 BIOM?RIEUX: COMPANY SNAPSHOT (2025)
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 41 DIASORIN S.P.A.: COMPANY SNAPSHOT (2025)
FIGURE 42 BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 43 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 44 AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 45 BLOOD CULTURE TESTS MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 46 PRIMARY SOURCES
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49 GLOBAL BLOOD CULTURE TESTS MARKET: REVENUE SHARE ANALYSIS
FIGURE 50 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 51 TOP-DOWN APPROACH
FIGURE 52 DATA TRIANGULATION METHODOLOGY
FIGURE 53 PARAMETRIC ASSUMPTIONS
FIGURE 1 BLOOD CULTURE TESTS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 GLOBAL BLOOD CULTURE TESTS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF BLOOD CULTURE TESTS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN BLOOD CULTURE TESTS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING BURDEN OF BLOODSTREAM INFECTIONS AND ANTIMICROBIAL RESISTANCE TO DRIVE MARKET GROWTH
FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10 AUTOMATED BLOOD CULTURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 CULTURE-BASED TECHNOLOGIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 BACTEREMIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 13 HOSPITAL-LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 15 BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 BLOOD CULTURE TESTS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18 BLOOD CULTURE TESTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 19 BLOOD CULTURE TESTS MARKET: ECOSYSTEM ANALYSIS
FIGURE 20 BLOOD CULTURE TESTS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 21 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD CULTURE TESTS MARKET
FIGURE 22 PATENT ANALYSIS FOR BLOOD CULTURE TESTS, JANUARY 2015–DECEMBER 2025
FIGURE 23 MARKET POTENTIAL OF AI IN BLOOD CULTURE TESTS MARKET
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 25 KEY BUYING CRITERIA, BY OFFERING
FIGURE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 27 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025 (USD MILLION)
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2025
FIGURE 30 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31 BLOOD CULTURE TESTS MARKET: COMPANY FOOTPRINT
FIGURE 32 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33 EV/EBITDA OF KEY VENDORS
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35 BLOOD CULTURE TESTS MARKET: BRAND/PRODUCT COMPARISON FOR AUTOMATED BLOOD CULTURE SYSTEMS
FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37 BIOM?RIEUX: COMPANY SNAPSHOT (2025)
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 41 DIASORIN S.P.A.: COMPANY SNAPSHOT (2025)
FIGURE 42 BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 43 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 44 AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 45 BLOOD CULTURE TESTS MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 46 PRIMARY SOURCES
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49 GLOBAL BLOOD CULTURE TESTS MARKET: REVENUE SHARE ANALYSIS
FIGURE 50 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 51 TOP-DOWN APPROACH
FIGURE 52 DATA TRIANGULATION METHODOLOGY
FIGURE 53 PARAMETRIC ASSUMPTIONS
